TMC114-TiDP29-C169: Bioavailability and Pharmacokinetics Trial Comparing Darunavir Pediatric Suspension Formulation to Current Darunavir Tablet

Categoría Estudio primario
Registro de estudiosclinicaltrials.gov
Año 2008
Cargando información sobre las referencias
The purpose of this study is to evaluate in healthy volunteers how much and how fast the new suspension compared to the commercial darunavir tablet, given in combination with low-dose ritonavir, are absorbed into the body (called the relative oral bioavailability).
Epistemonikos ID: 27802859576e219c03660ad8d8ad199f040e1b72
First added on: May 05, 2024